Related Experiment Video
Updated: Jan 27, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc
Frank Barletta1, Chi-Wai Wong, Chris McNally
1Department of Women's Health and Bone Research, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, USA.
Abstract:
In this study, we have evaluated the molecular mechanism of Src activation after its interaction with estrogen receptor alpha (ERalpha) and a newly identified scaffold protein, called MNAR (modulator of nongenomic activity of ER). Under basal condition, Src enzymatic activity is inhibited by intramolecular interactions. The enzyme can be activated by interaction between the SH2 domain of Src and phosphotyrosine-containing sequences and/or by interaction between the SH3 domain of Src and proteins containing PXXP motifs. Mutational analysis and functional evaluation of MNAR and the use of ERalpha and cSrc mutants revealed that MNAR interacts with Src's SH3 domain via its N-terminal PXXP motif. Mutation of this motif abolished both the MNAR-induced activation of Src and the stimulation of ER transcriptional activity. ER interacts with Src's SH2 domain using phosphotyrosine 537, and this complex was further stabilized by MNAR-ER interaction. Mapping studies reveal that both the A/B domain and Y537 of ERalpha are required for MNAR-induced activation of ER transcriptional activity. The region responsible for MNAR interaction with ER maps to two N-terminal LXXLL motifs of MNAR. Mutation of these motifs prevented ER-MNAR complex formation and eliminated activation of the Src/MAPK pathway. These data explicate how the coordinate interactions between MNAR, ER, and Src lead to Src activation. Our findings also demonstrate that MNAR is a scaffold protein that mediates ER-Src interaction and plays an important role in the integration of ER action in Src-mediated signaling.
Insights
The scaffold protein MNAR (modulator of nongenomic activity of ER) mediates estrogen receptor alpha (ERalpha) and Src interaction, activating Src kinase. MNAR facilitates ERalpha transcriptional activity and integrates ERalpha actions into Src-mediated signaling pathways.
Area of Science:
- Molecular biology
- Cell signaling
- Protein-protein interactions
Background:
- Src kinase activity is tightly regulated by intramolecular interactions.
- Src activation requires specific domain interactions, including SH2 and SH3 domains.
- Estrogen receptor alpha (ERalpha) plays a role in cellular signaling pathways.
Purpose of the Study:
- To elucidate the molecular mechanism of Src activation mediated by ERalpha and the scaffold protein MNAR.
- To define the specific interactions between MNAR, ERalpha, and Src.
- To understand MNAR's role in integrating ERalpha signaling with Src-mediated pathways.
Main Methods:
- Site-directed mutagenesis of MNAR, ERalpha, and Src.
- Functional assays to evaluate Src enzymatic activity and ERalpha transcriptional activity.
- Co-immunoprecipitation and mapping studies to determine protein-protein interaction domains.
Main Results:
- MNAR interacts with Src via its SH3 domain's PXXP motif, leading to Src activation.
- MNAR stabilizes the ERalpha-Src complex through interactions involving ERalpha's Y537 and MNAR's LXXLL motifs.
- MNAR is essential for ERalpha-induced Src/MAPK pathway activation and ERalpha transcriptional activity.
Conclusions:
- MNAR acts as a crucial scaffold protein, mediating the interaction between ERalpha and Src.
- MNAR's interactions are critical for both Src activation and ERalpha's transcriptional function.
- MNAR plays a significant role in integrating ERalpha signaling into Src-mediated cellular responses.
Related Concept Videos
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Quantitative Aspects of Drug-Receptor Interaction
Receptor-mediated Endocytosis
G-protein Coupled Receptors

